HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

anrukinzumab

an anti-interleukin 13 monoclonal antibody
Also Known As:
IMA-638
Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Kasaian, Marion T: 2 articles (04/2011 - 03/2007)
2. Cataldi, Fabio: 1 article (07/2015)
3. Hua, Fei: 1 article (07/2015)
4. Martin, Steven: 1 article (07/2015)
5. Reinisch, Walter: 1 article (07/2015)
6. Ribbing, Jakob: 1 article (07/2015)
7. Boulet, Louis-Philippe: 1 article (04/2011)
8. Carlsten, Chris: 1 article (04/2011)
9. Cockcroft, Donald W: 1 article (04/2011)
10. Davis, Beth E: 1 article (04/2011)

Related Diseases

1. Asthma (Bronchial Asthma)
07/01/2015 - "UC patients were identified to have a faster CL of anrukinzumab than healthy volunteers and asthma patients. "
04/15/2011 - "Fifty-six subjects with mild, atopic asthma were recruited for two double-blind, randomized, placebo-controlled, parallel group trials to compare IMA-638 and IMA-026 IL-13 antibody treatments with placebo treatment. "
07/01/2015 - "A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients."
01/01/2023 - "The search strategies were as follows: topic: TS=(biologic* OR "biologic* product*" OR "biologic* therap*" OR biotherapy* OR "biologic* agent*" OR Benralizumab OR "MEDI-563" OR Fasenra OR "BIW-8405" OR Dupilumab OR SAR231893 OR "SAR-231893" OR Dupixent OR REGN668 OR "REGN-668" OR Mepolizumab OR Bosatria OR "SB-240563" OR SB240563 OR Nucala OR Omalizumab OR Xolair OR Reslizumab OR "SCH-55700" OR SCH55700 OR "CEP-38072" OR CEP38072 OR Cinqair OR "DCP-835" OR DCP835 OR Tezspire OR "tezepelumab-ekko" OR "AMG-157" OR tezspire OR "MEDI-9929" OR "MEDI-19929" OR MEDI9929 OR Itepekimab OR "REGN-3500"OR REGN3500 OR "SAR-440340"OR SAR440340 OR Tralokinumab OR "CAT-354" OR Anrukinzumab OR "IMA-638" OR Lebrikizumab OR "RO-5490255"OR "RG-3637"OR "TNX-650"OR "MILR1444A"OR "MILR-1444A"OR"PRO301444"OR "PRO-301444"OR Pitrakinra OR altrakincept OR "AMG-317"OR"AMG317" OR Etokimab OR Pascolizumab OR "IMA-026"OR Enokizumab OR "MEDI-528"OR "7F3COM-2H2" OR 7F3COM2H2 OR Brodalumab OR "KHK-4827" OR "KHK4827"OR "AMG-827"OR Siliq OR Ligelizumab OR "QGE-031" OR QGE031 OR Quilizumab OR Talizumab OR "TNX-901" OR TNX901 OR Infliximab OR Etanercept OR "PRS-060") AND TS=asthma*. "
2. Respiratory Hypersensitivity
3. Hypersensitivity (Allergy)
4. Ulcerative Colitis

Related Drugs and Biologics

1. Interleukin-13
2. Immunoglobulin G (IgG)
3. Antigens
4. Monoclonal Antibodies
5. Omalizumab (Xolair)
6. Infliximab (Remicade)
7. Etanercept (Enbrel)
8. dupilumab
9. tralokinumab
10. benralizumab

Related Therapies and Procedures

1. Biological Therapy